original ) (raw )Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters
Francesco Trotta , Andrea Lo Monaco
Rheumatology International, 2011
View PDFchevron_right
Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis
Donald Tashkin
Arthritis & Rheumatism, 2004
View PDFchevron_right
Cytokine concentrations in bronchoalveolar lavage fluid of patients with systemic sclerosis
Charlie Strange
Arthritis & Rheumatism, 1997
View PDFchevron_right
The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review
Lorenzo Tofani
Pharmaceuticals
View PDFchevron_right
British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival
Robin Prescott
Thorax, 2007
View PDFchevron_right
Prognostic indicators in extrinsic allergic alveolitis
Herbert Publications
View PDFchevron_right
Diffuse alveolar damage in patients with dermatomyositis: a six-case series
Toshikazu Kano
Modern Rheumatology, 2012
View PDFchevron_right
Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease
Yasin Abul
Rheumatology International
View PDFchevron_right
Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis
Gunilla Westergren-thorsson
Respiratory medicine, 2013
View PDFchevron_right
Interstitial Vascularity in Fibrosing Alveolitis
Piersante Sestini
American Journal of Respiratory and Critical Care Medicine, 2003
View PDFchevron_right
Bronchoalveolar Lavage Fluid in Scleroderma Interstitial Lung Disease: Technical Aspects and Clinical Correlations: Review of the Literature
Richard Silver
Seminars in Arthritis and Rheumatism, 2010
View PDFchevron_right
Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease
Robert Wise
Arthritis & Rheumatism, 2007
View PDFchevron_right
High-Resolution Computed Tomography and Survival in Fibrosing Alveolitis
Omer Alamoudi
Asian Cardiovascular and Thoracic Annals, 2000
View PDFchevron_right
The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases
layla tahiri
Journal of Negative Results in BioMedicine, 2017
View PDFchevron_right
Induced Sputum in Systemic Sclerosis Interstitial Lung Disease: Comparison to Healthy Controls and Bronchoalveolar Lavage
Bane Nestorovic
Respiration, 2009
View PDFchevron_right
British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society
Robin Prescott
Thorax, 1997
View PDFchevron_right
Systemic sclerosis-associated interstitial pneumonia: evaluation of pulmonary function over a five-year period
Agnaldo Lopes , Fernando Guimaraes
Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2011
View PDFchevron_right
Bronchoalveolar lavage improves diagnostic accuracy in patients with diffuse lung disease
Edwin Parra
Diagnostic Cytopathology, 2013
View PDFchevron_right
4th International Conference on Bronchoalveolar Lavage, organized by the European BAL Task Group
Heinrich Klech
European Respiratory Journal, 1994
View PDFchevron_right
Oral cyclophosphamide improves pulmonary function in scleroderma patients with fibrosing alveolitis: experience in one centre
Lorenzo Beretta
Clinical Rheumatology, 2006
View PDFchevron_right
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis
Jonathan Goldin , D. Schraufnagel
Annals of the Rheumatic Diseases, 2007
View PDFchevron_right
Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis–associated interstitial lung disease are not predictive of disease progression
Athol Wells
Arthritis & Rheumatism, 2007
View PDFchevron_right
Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations
Krzysztof Kowal , Anna Bodzenta-lukaszyk
Annals of the Rheumatic Diseases, 2005
View PDFchevron_right
Interstitial Lung disease in Systemic Sclerosis. An HRCT-clinical correlative study
Toby Maher , George Margaritopoulos
Acta Radiologica, 2003
View PDFchevron_right
Pulmonary involvement in diffuse cutaneous systemic sclerosis: broncheoalveolar fluid granulocytosis predicts progression of fibrosing alveolitis
Ingo Fietze
Annals of the Rheumatic Diseases, 1999
View PDFchevron_right
David against Goliath: may we target and defeat interstitial lung disease in systemic sclerosis?
Peter ten Klooster
2007
View PDFchevron_right
Analysis of bronchoalveolar lavage fluid in a first Romanian pulmonary alveolar proteinosis cohort
oana arghir
PubMed, 2016
View PDFchevron_right
Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis
David Lamb
Thorax, 1994
View PDFchevron_right